Reset Map4 Results
1 Evertrust Plz Suite 1104 Jersey City, NJ, 07302 United StatesThe Amaris Health Economics and Market Access (HEMA) brings together people of diverse backgrounds and combines robust quantitative and qualitative methods in order to provide a range of solutions to our pharmaceutical, biotech and medical device clients. Amaris HEMA is a global team of over 70 consultants spread out in 8 different offices around the world (Europe, North America and APAC). Our activities cover three main practices areas: - Health Economics Modelling (Cost-Effectiveness, Budget Impact, Sequential Modelling, Dynamic Modelling etc.) at both the global and the local levels (model adaptations) - RWE and Biostatistics (Secondary database analysis, Primary data collection, MAIC, ITC, NMAs etc.) - Evidence, Value and Access (SLRs, TLRs, GVDs, Landscape assessments, Evidence generation plans, KOL interviews etc.) The three Amaris HEMA practice areas collaborate on evidence review/package projects such as HTA submissions, with extensive experience in Canada, UK, France etc. Our profound understanding of the pharmaceutical market and solid scientific background makes us a valuable and reliable partner along all phases of development. We have strong expertise in both very specific and technical projects. Amaris’ added value lies in the quality of its teams and their attention to detail, as well as in the way the company capitalizes on their knowhow. Every employee is encouraged to develop a proactive, efficiency-oriented working style in order to provide only the most innovative solutions. The Health Economics and Market Access (HEMA) department of Amaris is part of the Amaris Group (http://amaris.com/en), an independent consulting company specialized in technology and management. Founded in 2007 in Switzerland, Amaris now employs more than 6,500 people based in more than 65 offices in 45 countries. Amaris provides services with a strong added value in all business sectors through five business lines: - Business & Management consulting - Information Systems and Technologies - Engineering and High technology - Telecommunications - Life Sciences (including Amaris HEMA).
Amaris - Work.Life 13 Hawley Crescent LONDON, NW1 8NP United KingdomThe Amaris Health Economics and Market Access (HEMA) brings together people of diverse backgrounds and combines robust quantitative and qualitative methods in order to provide a range of solutions to our pharmaceutical, biotech and medical device clients. Amaris HEMA is a global team of over 70 consultants spread out in 8 different offices around the world (Europe, North America and APAC). Our activities cover three main practices areas: - Health Economics Modelling (Cost-Effectiveness, Budget Impact, Sequential Modelling, Dynamic Modelling etc.) at both the global and the local levels (model adaptations) - RWE and Biostatistics (Secondary database analysis, Primary data collection, MAIC, ITC, NMAs etc.) - Evidence, Value and Access (SLRs, TLRs, GVDs, Landscape assessments, Evidence generation plans, KOL interviews etc.) The three Amaris HEMA practice areas collaborate on evidence review/package projects such as HTA submissions, with extensive experience in Canada, UK, France etc. Our profound understanding of the pharmaceutical market and solid scientific background makes us a valuable and reliable partner along all phases of development. We have strong expertise in both very specific and technical projects. Amaris’ added value lies in the quality of its teams and their attention to detail, as well as in the way the company capitalizes on their knowhow. Every employee is encouraged to develop a proactive, efficiency-oriented working style in order to provide only the most innovative solutions. The Health Economics and Market Access (HEMA) department of Amaris is part of the Amaris Group (http://amaris.com/en), an independent consulting company specialized in technology and management. Founded in 2007 in Switzerland, Amaris now employs more than 6,500 people based in more than 65 offices in 45 countries. Amaris provides services with a strong added value in all business sectors through five business lines: - Business & Management consulting - Information Systems and Technologies - Engineering and High technology - Telecommunications - Life Sciences (including Amaris HEMA).
13 Hwaley Street Camden Town London, NW18NP United KingdomThe Amaris Health Economics and Market Access (HEMA) brings together people of diverse backgrounds and combines robust quantitative and qualitative methods in order to provide a range of solutions to our pharmaceutical, biotech and medical device clients. Amaris HEMA is a global team of over 70 consultants spread out in 8 different offices around the world (Europe, North America and APAC). Our activities cover three main practices areas: - Health Economics Modelling (Cost-Effectiveness, Budget Impact, Sequential Modelling, Dynamic Modelling etc.) at both the global and the local levels (model adaptations) - RWE and Biostatistics (Secondary database analysis, Primary data collection, MAIC, ITC, NMAs etc.) - Evidence, Value and Access (SLRs, TLRs, GVDs, Landscape assessments, Evidence generation plans, KOL interviews etc.) The three Amaris HEMA practice areas collaborate on evidence review/package projects such as HTA submissions, with extensive experience in Canada, UK, France etc. Our profound understanding of the pharmaceutical market and solid scientific background makes us a valuable and reliable partner along all phases of development. We have strong expertise in both very specific and technical projects. Amaris’ added value lies in the quality of its teams and their attention to detail, as well as in the way the company capitalizes on their knowhow. Every employee is encouraged to develop a proactive, efficiency-oriented working style in order to provide only the most innovative solutions. The Health Economics and Market Access (HEMA) department of Amaris is part of the Amaris Group (http://amaris.com/en), an independent consulting company specialized in technology and management. Founded in 2007 in Switzerland, Amaris now employs more than 6,500 people based in more than 65 offices in 45 countries. Amaris provides services with a strong added value in all business sectors through five business lines: - Business & Management consulting - Information Systems and Technologies - Engineering and High technology - Telecommunications - Life Sciences (including Amaris HEMA).
110 Yonge Street toronto Toronto, ON, M5C 1T4 CanadaThe Amaris Health Economics and Market Access (HEMA) brings together people of diverse backgrounds and combines robust quantitative and qualitative methods in order to provide a range of solutions to our pharmaceutical, biotech and medical device clients. Amaris HEMA is a global team of over 70 consultants spread out in 8 different offices around the world (Europe, North America and APAC). Our activities cover three main practices areas: - Health Economics Modelling (Cost-Effectiveness, Budget Impact, Sequential Modelling, Dynamic Modelling etc.) at both the global and the local levels (model adaptations) - RWE and Biostatistics (Secondary database analysis, Primary data collection, MAIC, ITC, NMAs etc.) - Evidence, Value and Access (SLRs, TLRs, GVDs, Landscape assessments, Evidence generation plans, KOL interviews etc.) The three Amaris HEMA practice areas collaborate on evidence review/package projects such as HTA submissions, with extensive experience in Canada, UK, France etc. Our profound understanding of the pharmaceutical market and solid scientific background makes us a valuable and reliable partner along all phases of development. We have strong expertise in both very specific and technical projects. Amaris’ added value lies in the quality of its teams and their attention to detail, as well as in the way the company capitalizes on their knowhow. Every employee is encouraged to develop a proactive, efficiency-oriented working style in order to provide only the most innovative solutions. The Health Economics and Market Access (HEMA) department of Amaris is part of the Amaris Group (http://amaris.com/en), an independent consulting company specialized in technology and management. Founded in 2007 in Switzerland, Amaris now employs more than 6,500 people based in more than 65 offices in 45 countries. Amaris provides services with a strong added value in all business sectors through five business lines: - Business & Management consulting - Information Systems and Technologies - Engineering and High technology - Telecommunications - Life Sciences (including Amaris HEMA).
Site Information
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
What is Scientist.com?
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
How can I use Scientist.com?
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Why should I place my order through Scientist.com?
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
How do I get my organization listed on the map?
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Information about my organization is incorrect, how do I fix it?
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.